Abbott Id Now | search
Click here to view Abbott Id Now news from 60+ newspapers.
Bookmark or Share- ID NOW COVID-19 2.0 | Abbott Point of CareCOVID-19 2.0. FLEXIBLE TESTING. FLEXIBLE WORKFLOW. ID NOW™ COVID-19 2.0 detects SARS-CoV-2 in 6‑12 minutes with the option to add on an ID NOW Influenza A & B 2 test without collecting another sample. FDA cleared. CLIA waived. Contact Sales. Technical Support. Overview. Benefits. Helpful Documents. Related Products. Benefits.
- ID NOW COVID-19 Testing Questions Answered | Abbott U.S.The ID NOW COVID-19 test is a rapid, molecular point-of-care test that detects COVID-19 in 13 minutes or less. It is used on our ID NOW platform. Abbott received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the ID NOW COVID-19 test in March 2020.
- Find ID NOW Test Locations | Abbott Point of CareID NOW™ rapid molecular instrument provides your healthcare professional with timely results, that inform your treatment. Find a testing location.
- ID NOW | Abbott Point of CareThe ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner. Contact Sales.
- ID NOW Performance, From Researchers in the Field | Newsroom - AbbottID NOW's test for COVID-19 is proving to be an essential tool in fighting this pandemic as it is the fastest and most widely available rapid point of care test. Its portability and speed are allowing it to be used in some of the most critical settings where results in minutes are needed.
More
